Sotera Health SHC Gain (loss) on mark-to-market of Escrowed Shares
Gain (loss) on mark-to-market of Escrowed Shares at other companies
Other financials
Where this comes from
Reported directly by Sotera Health in its filing.
Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnDerivatives.
The official record: Sotera Health’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sotera Health's gain (loss) on mark-to-market of escrowed shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sotera Health's gain (loss) on mark-to-market of escrowed shares?
- Sotera Health (SHC) reported gain (loss) on mark-to-market of escrowed shares of -$1.19M in Q1 2026.
- How has Sotera Health's gain (loss) on mark-to-market of escrowed shares changed year-over-year?
- Sotera Health's gain (loss) on mark-to-market of escrowed shares increased by 25.6% year-over-year, from -$1.6M to -$1.19M.
- What does gain (loss) on mark-to-market of escrowed shares mean?
- This represents the change in the fair value of derivative financial instruments that have not yet been settled. These instruments are typically used to hedge risks such as interest rate fluctuations, commodity price changes, or foreign exchange exposure. It provides insight into the effectiveness and market-driven valuation of the company's hedging strategy.